1 completed, 1 enrolling by invitation. .
Follow Adera Labs, LLC: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Exceptional Responders With Solid Tumor Cancer to Chemotherapy Standard of Care Chemotherapy - Solid Tumor Neoplasms | Enrolling by invitation | Adera Labs, LLC | 250 | 2015-10-01 | 2023-02-01 | |
| Feasibility of Obtaining and Characterizing Circulating Tumorigenic Cells in Patients With Pancreatic Adenocarcinoma Blood draw - Pancreatic Adenocarcinoma | Completed | Memorial Sloan Kettering Cancer Center | 83 | 2011-11-01 | 2019-10-02 |
United States (2)
Brian McCarthy, PhD (1) · Kenneth Yu, M.D., M.Sc. (1)